The Meso Foundation released a statement from its executive director, Mary Hesdorffer, APRN, about AstraZeneca’s tremelimumab trial for mesothelioma. In an AstraZeneca press release issued…
1717 K Street NW, Suite 900
Washington, DC 20006-5349
(877) 363-6376
HELPLINE
